Beth Soffer

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi request reprint A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension
    Beth Soffer
    Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Hypertens 16:795-800. 2003
  2. ncbi request reprint A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension
    Thomas Wells
    University of Arkansas for Medical Sciences and Arkansas Children s Hospital, Little Rock 72202, USA
    J Clin Pharmacol 42:870-80. 2002
  3. ncbi request reprint Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial
    Herbert S B Baraf
    Center for Rheumatology and Bone Research, Wheaton, Maryland 20902, USA
    J Rheumatol 34:408-20. 2007

Collaborators

  • Shahnaz Shahinfar
  • S P Curtis
  • Herbert S B Baraf
  • Thomas Wells
  • Jan Brzezicki
  • Adam Polis
  • Maria Greenwald
  • Katherine O'Brien
  • Carlos Fuentealba
  • Steven Bird
  • Amarjot Kaur
  • Zhongxin Zhang
  • Wayne Shaw
  • Virginia Frame
  • Pamela Herrera

Detail Information

Publications3

  1. ncbi request reprint A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension
    Beth Soffer
    Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Hypertens 16:795-800. 2003
    ..Despite widespread use in hypertensive children, the safety and effectiveness of lisinopril had not been previously tested in a controlled study...
  2. ncbi request reprint A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension
    Thomas Wells
    University of Arkansas for Medical Sciences and Arkansas Children s Hospital, Little Rock 72202, USA
    J Clin Pharmacol 42:870-80. 2002
    ..08 mg/kg) administered once daily effectively lowered blood pressure within 2 weeks in most patients. Blood pressure was reduced in a dose-dependent fashion, with larger doses resulting in a greater reduction...
  3. ncbi request reprint Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial
    Herbert S B Baraf
    Center for Rheumatology and Bone Research, Wheaton, Maryland 20902, USA
    J Rheumatol 34:408-20. 2007
    ..To compare the gastrointestinal (GI) tolerability, safety, and efficacy of etoricoxib and diclofenac in patients with osteoarthritis (OA)...